Innate immunity and the role of defensins in otitis media
- PMID: 21901304
- PMCID: PMC3208749
- DOI: 10.1007/s11882-011-0223-6
Innate immunity and the role of defensins in otitis media
Abstract
Otitis media is the most common pediatric disease in developed countries and a significant cause of morbidity and hearing loss in developing countries. The innate immune system is essential to protecting the middle ear from infection. Defensins, broad-spectrum cationic antimicrobial peptides, have been implicated in prevention of and the early response to acute otitis media; however, the mechanisms by which defensins and other antimicrobial molecules mediate this protection have not been completely elucidated. In both animal otitis media models and human middle ear epithelial cell culture models, β-defensins are highly induced and effectively kill the common pathogens associated with otitis media. We review the importance of innate immunity in protecting the middle ear and recent advances in understanding the roles of defensins and other antimicrobial molecules in the prevention and treatment of otitis media. The extremely high prevalence of otitis media, in spite of sophisticated innate and adaptive immune systems, is a vexing problem for clinicians and scientists. We therefore also review mechanisms by which bacteria evade innate immune defenses.
Conflict of interest statement
Dr. Underwood reported no potential conflicts of interest relevant to this article.
Figures

Similar articles
-
Role of innate immunity in the pathogenesis of otitis media.Int J Infect Dis. 2014 Dec;29:259-67. doi: 10.1016/j.ijid.2014.10.015. Epub 2014 Nov 5. Int J Infect Dis. 2014. PMID: 25447732 Free PMC article. Review.
-
Expression of beta-defensins in the tubotympanum of experimental otitis media.Acta Otolaryngol. 2006 Oct;126(10):1040-5. doi: 10.1080/00016480600672626. Acta Otolaryngol. 2006. PMID: 16923707
-
Defensin-barbed innate immunity: clinical associations in the pediatric population.Pediatrics. 2010 Jun;125(6):1237-47. doi: 10.1542/peds.2009-3289. Epub 2010 May 17. Pediatrics. 2010. PMID: 20478936 Review.
-
Subversion of host immune responses by otopathogens during otitis media.J Leukoc Biol. 2019 Oct;106(4):943-956. doi: 10.1002/JLB.4RU0119-003R. Epub 2019 May 10. J Leukoc Biol. 2019. PMID: 31075181 Free PMC article. Review.
-
Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae.BMC Infect Dis. 2004 May 5;4:12. doi: 10.1186/1471-2334-4-12. BMC Infect Dis. 2004. PMID: 15125783 Free PMC article.
Cited by
-
Immunomodulatory Response of the Middle Ear Epithelial Cells in Otitis Media.Otol Neurotol. 2024 Mar 1;45(3):e248-e255. doi: 10.1097/MAO.0000000000004096. Epub 2024 Jan 17. Otol Neurotol. 2024. PMID: 38238924 Free PMC article.
-
Human antimicrobial peptides and proteins.Pharmaceuticals (Basel). 2014 May 13;7(5):545-94. doi: 10.3390/ph7050545. Pharmaceuticals (Basel). 2014. PMID: 24828484 Free PMC article.
-
Blocking macrophage migration inhibitory factor activity alleviates mouse acute otitis media in vivo.Immunol Lett. 2014 Nov;162(1 Pt A):101-8. doi: 10.1016/j.imlet.2014.07.013. Epub 2014 Aug 6. Immunol Lett. 2014. PMID: 25108100 Free PMC article.
-
High concentrations of middle ear antimicrobial peptides and proteins and proinflammatory cytokines are associated with detection of middle ear pathogens in children with recurrent acute otitis media.PLoS One. 2019 Dec 26;14(12):e0227080. doi: 10.1371/journal.pone.0227080. eCollection 2019. PLoS One. 2019. PMID: 31877198 Free PMC article.
-
Translating Recent Microbiome Insights in Otitis Media into Probiotic Strategies.Clin Microbiol Rev. 2019 Jul 3;32(4):e00010-18. doi: 10.1128/CMR.00010-18. Print 2019 Sep 18. Clin Microbiol Rev. 2019. PMID: 31270125 Free PMC article. Review.
References
-
- Taylor PS, Faeth I, Marks MK, Del Mar CB, Skull SA, Pezzullo ML, Havyatt SM, Coates HL. Cost of treating otitis media in Australia. Expert Rev Pharmacoecon Outcomes Res. 2009;9:133–141. - PubMed
-
- Coyte PC, Asche CV, Elden LM. The economic cost of otitis media in Canada. Int J Pediatr Otorhinolaryngol. 1999;49:27–36. - PubMed
-
- O’Brien MA, Prosser LA, Paradise JL, Ray GT, Kulldorff M, Kurs-Lasky M, Hinrichsen VL, Mehta J, Colborn DK, Lieu TA. New vaccines against otitis media: projected benefits and cost-effectiveness. Pediatrics. 2009;123:1452–1463. - PubMed
-
- Post JC, Hiller NL, Nistico L, Stoodley P, Ehrlich GD. The role of biofilms in otolaryngologic infections: update 2007. Curr Opin Otolaryngol Head Neck Surg. 2007;15:347–351. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical